Pyronaridine

Pyronaridine is an antimalarial drug. It was first made in 1970 and has been in clinical use in China since the 1980s.
It is one of the components of the artemisinin combination therapy pyronaridine/artesunate (Pyramax).
It has also been studied as a potential anticancer drug, treatment for Ebola. The combination of pyronaridine and artesunate has been evaluated to have a synergistic effect of stronger antiviral effect and less toxicity. The combination of pyronaridine and artesunate is being studied as a possible treatment for moderate to severe SARS-COV-2.